BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy
Objective: Clinical and biological correlates of resilience in major depressive disorder are scarce. We aimed to investigate the effect of the Val66Met polymorphism in the BDNF gene on resilience scores in major depressive disorder patients and evaluate the polymorphism’s moderation effect on resili...
Ausführliche Beschreibung
Autor*in: |
Renata B. Peters [verfasserIn] Janaína Xavier [verfasserIn] Thaíse C. Mondin [verfasserIn] Taiane de A. Cardoso [verfasserIn] Fabiana B. Ferreira [verfasserIn] Liana Teixeira [verfasserIn] Kiane Gräeff [verfasserIn] Luciana de A. Quevedo [verfasserIn] Karen Jansen [verfasserIn] Luciano D. Souza [verfasserIn] Jean P. Oses [verfasserIn] Ricardo T. Pinheiro [verfasserIn] Ricardo A. da Silva [verfasserIn] Gabriele Ghisleni [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch ; Portugiesisch |
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Brazilian Journal of Psychiatry - Associação Brasileira de Psiquiatria (ABP), 2004 |
---|
Links: |
Link aufrufen |
---|
DOI / URN: |
10.1590/1516-4446-2019-0726 |
---|
Katalog-ID: |
DOAJ064381137 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ064381137 | ||
003 | DE-627 | ||
005 | 20230309035625.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230228nuuuuuuuuxx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1590/1516-4446-2019-0726 |2 doi | |
035 | |a (DE-627)DOAJ064381137 | ||
035 | |a (DE-599)DOAJa1c68762b68a403aaf41dd2282d16d04 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng |a por | ||
050 | 0 | |a RC435-571 | |
100 | 0 | |a Renata B. Peters |e verfasserin |4 aut | |
245 | 1 | 0 | |a BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Objective: Clinical and biological correlates of resilience in major depressive disorder are scarce. We aimed to investigate the effect of the Val66Met polymorphism in the BDNF gene on resilience scores in major depressive disorder patients and evaluate the polymorphism’s moderation effect on resilience scores in response to cognitive therapy. Method: A total of 106 major depressive disorder patients were enrolled in this clinical randomized study. The Resilience Scale and the Hamilton Rating Scale for Depression were applied at baseline, post-treatment, and at six months of follow-up. Blood samples were obtained at baseline for molecular analysis. Results: The baseline resilience scores were higher in patients with the Met allele (114.6±17.6) than in those with the Val/Val genotype (104.04±21.05; p = 0.037). Cognitive therapy treatment increased resilience scores (p ≤ 0.001) and decreased depressive symptoms (p ≤ 0.001). In the mixed-effect model, the Val/Val genotype represented a decrease in resilience scores (t218 = -1.98; p = 0.048), and the Val66Met polymorphism interacted with sex to predict an increase in total resilience scores during cognitive treatment (t218 = 2.69; p = 0.008). Conclusion: Our results indicate that cognitive therapy intervention could improve resilience in follow-up, considering that gender and genetic susceptibility are predicted by the Val66Met polymorphism. | ||
650 | 4 | |a Resilience | |
650 | 4 | |a Val66Met polymorphism | |
650 | 4 | |a psychotherapy | |
653 | 0 | |a Psychiatry | |
700 | 0 | |a Janaína Xavier |e verfasserin |4 aut | |
700 | 0 | |a Thaíse C. Mondin |e verfasserin |4 aut | |
700 | 0 | |a Taiane de A. Cardoso |e verfasserin |4 aut | |
700 | 0 | |a Fabiana B. Ferreira |e verfasserin |4 aut | |
700 | 0 | |a Liana Teixeira |e verfasserin |4 aut | |
700 | 0 | |a Kiane Gräeff |e verfasserin |4 aut | |
700 | 0 | |a Luciana de A. Quevedo |e verfasserin |4 aut | |
700 | 0 | |a Karen Jansen |e verfasserin |4 aut | |
700 | 0 | |a Luciano D. Souza |e verfasserin |4 aut | |
700 | 0 | |a Jean P. Oses |e verfasserin |4 aut | |
700 | 0 | |a Ricardo T. Pinheiro |e verfasserin |4 aut | |
700 | 0 | |a Ricardo A. da Silva |e verfasserin |4 aut | |
700 | 0 | |a Gabriele Ghisleni |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Brazilian Journal of Psychiatry |d Associação Brasileira de Psiquiatria (ABP), 2004 |w (DE-627)320632717 |w (DE-600)2024119-7 |x 1809452X |7 nnns |
856 | 4 | 0 | |u https://doi.org/10.1590/1516-4446-2019-0726 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/a1c68762b68a403aaf41dd2282d16d04 |z kostenfrei |
856 | 4 | 0 | |u http://www.scielo.br/pdf/rbp/v43n1/1516-4446-rbp-1516444620190726.pdf |z kostenfrei |
856 | 4 | 0 | |u http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462021000100006&tlng=en |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1809-452X |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR |
author_variant |
r b p rbp j x jx t c m tcm t d a c tdac f b f fbf l t lt k g kg l d a q ldaq k j kj l d s lds j p o jpo r t p rtp r a d s rads g g gg |
---|---|
matchkey_str |
article:1809452X:uuuuuuuu::dfa6mtoyopimnrslecimjrersieiodrhip |
callnumber-subject-code |
RC |
allfields |
10.1590/1516-4446-2019-0726 doi (DE-627)DOAJ064381137 (DE-599)DOAJa1c68762b68a403aaf41dd2282d16d04 DE-627 ger DE-627 rakwb eng por RC435-571 Renata B. Peters verfasserin aut BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Objective: Clinical and biological correlates of resilience in major depressive disorder are scarce. We aimed to investigate the effect of the Val66Met polymorphism in the BDNF gene on resilience scores in major depressive disorder patients and evaluate the polymorphism’s moderation effect on resilience scores in response to cognitive therapy. Method: A total of 106 major depressive disorder patients were enrolled in this clinical randomized study. The Resilience Scale and the Hamilton Rating Scale for Depression were applied at baseline, post-treatment, and at six months of follow-up. Blood samples were obtained at baseline for molecular analysis. Results: The baseline resilience scores were higher in patients with the Met allele (114.6±17.6) than in those with the Val/Val genotype (104.04±21.05; p = 0.037). Cognitive therapy treatment increased resilience scores (p ≤ 0.001) and decreased depressive symptoms (p ≤ 0.001). In the mixed-effect model, the Val/Val genotype represented a decrease in resilience scores (t218 = -1.98; p = 0.048), and the Val66Met polymorphism interacted with sex to predict an increase in total resilience scores during cognitive treatment (t218 = 2.69; p = 0.008). Conclusion: Our results indicate that cognitive therapy intervention could improve resilience in follow-up, considering that gender and genetic susceptibility are predicted by the Val66Met polymorphism. Resilience Val66Met polymorphism psychotherapy Psychiatry Janaína Xavier verfasserin aut Thaíse C. Mondin verfasserin aut Taiane de A. Cardoso verfasserin aut Fabiana B. Ferreira verfasserin aut Liana Teixeira verfasserin aut Kiane Gräeff verfasserin aut Luciana de A. Quevedo verfasserin aut Karen Jansen verfasserin aut Luciano D. Souza verfasserin aut Jean P. Oses verfasserin aut Ricardo T. Pinheiro verfasserin aut Ricardo A. da Silva verfasserin aut Gabriele Ghisleni verfasserin aut In Brazilian Journal of Psychiatry Associação Brasileira de Psiquiatria (ABP), 2004 (DE-627)320632717 (DE-600)2024119-7 1809452X nnns https://doi.org/10.1590/1516-4446-2019-0726 kostenfrei https://doaj.org/article/a1c68762b68a403aaf41dd2282d16d04 kostenfrei http://www.scielo.br/pdf/rbp/v43n1/1516-4446-rbp-1516444620190726.pdf kostenfrei http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462021000100006&tlng=en kostenfrei https://doaj.org/toc/1809-452X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR |
spelling |
10.1590/1516-4446-2019-0726 doi (DE-627)DOAJ064381137 (DE-599)DOAJa1c68762b68a403aaf41dd2282d16d04 DE-627 ger DE-627 rakwb eng por RC435-571 Renata B. Peters verfasserin aut BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Objective: Clinical and biological correlates of resilience in major depressive disorder are scarce. We aimed to investigate the effect of the Val66Met polymorphism in the BDNF gene on resilience scores in major depressive disorder patients and evaluate the polymorphism’s moderation effect on resilience scores in response to cognitive therapy. Method: A total of 106 major depressive disorder patients were enrolled in this clinical randomized study. The Resilience Scale and the Hamilton Rating Scale for Depression were applied at baseline, post-treatment, and at six months of follow-up. Blood samples were obtained at baseline for molecular analysis. Results: The baseline resilience scores were higher in patients with the Met allele (114.6±17.6) than in those with the Val/Val genotype (104.04±21.05; p = 0.037). Cognitive therapy treatment increased resilience scores (p ≤ 0.001) and decreased depressive symptoms (p ≤ 0.001). In the mixed-effect model, the Val/Val genotype represented a decrease in resilience scores (t218 = -1.98; p = 0.048), and the Val66Met polymorphism interacted with sex to predict an increase in total resilience scores during cognitive treatment (t218 = 2.69; p = 0.008). Conclusion: Our results indicate that cognitive therapy intervention could improve resilience in follow-up, considering that gender and genetic susceptibility are predicted by the Val66Met polymorphism. Resilience Val66Met polymorphism psychotherapy Psychiatry Janaína Xavier verfasserin aut Thaíse C. Mondin verfasserin aut Taiane de A. Cardoso verfasserin aut Fabiana B. Ferreira verfasserin aut Liana Teixeira verfasserin aut Kiane Gräeff verfasserin aut Luciana de A. Quevedo verfasserin aut Karen Jansen verfasserin aut Luciano D. Souza verfasserin aut Jean P. Oses verfasserin aut Ricardo T. Pinheiro verfasserin aut Ricardo A. da Silva verfasserin aut Gabriele Ghisleni verfasserin aut In Brazilian Journal of Psychiatry Associação Brasileira de Psiquiatria (ABP), 2004 (DE-627)320632717 (DE-600)2024119-7 1809452X nnns https://doi.org/10.1590/1516-4446-2019-0726 kostenfrei https://doaj.org/article/a1c68762b68a403aaf41dd2282d16d04 kostenfrei http://www.scielo.br/pdf/rbp/v43n1/1516-4446-rbp-1516444620190726.pdf kostenfrei http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462021000100006&tlng=en kostenfrei https://doaj.org/toc/1809-452X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR |
allfields_unstemmed |
10.1590/1516-4446-2019-0726 doi (DE-627)DOAJ064381137 (DE-599)DOAJa1c68762b68a403aaf41dd2282d16d04 DE-627 ger DE-627 rakwb eng por RC435-571 Renata B. Peters verfasserin aut BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Objective: Clinical and biological correlates of resilience in major depressive disorder are scarce. We aimed to investigate the effect of the Val66Met polymorphism in the BDNF gene on resilience scores in major depressive disorder patients and evaluate the polymorphism’s moderation effect on resilience scores in response to cognitive therapy. Method: A total of 106 major depressive disorder patients were enrolled in this clinical randomized study. The Resilience Scale and the Hamilton Rating Scale for Depression were applied at baseline, post-treatment, and at six months of follow-up. Blood samples were obtained at baseline for molecular analysis. Results: The baseline resilience scores were higher in patients with the Met allele (114.6±17.6) than in those with the Val/Val genotype (104.04±21.05; p = 0.037). Cognitive therapy treatment increased resilience scores (p ≤ 0.001) and decreased depressive symptoms (p ≤ 0.001). In the mixed-effect model, the Val/Val genotype represented a decrease in resilience scores (t218 = -1.98; p = 0.048), and the Val66Met polymorphism interacted with sex to predict an increase in total resilience scores during cognitive treatment (t218 = 2.69; p = 0.008). Conclusion: Our results indicate that cognitive therapy intervention could improve resilience in follow-up, considering that gender and genetic susceptibility are predicted by the Val66Met polymorphism. Resilience Val66Met polymorphism psychotherapy Psychiatry Janaína Xavier verfasserin aut Thaíse C. Mondin verfasserin aut Taiane de A. Cardoso verfasserin aut Fabiana B. Ferreira verfasserin aut Liana Teixeira verfasserin aut Kiane Gräeff verfasserin aut Luciana de A. Quevedo verfasserin aut Karen Jansen verfasserin aut Luciano D. Souza verfasserin aut Jean P. Oses verfasserin aut Ricardo T. Pinheiro verfasserin aut Ricardo A. da Silva verfasserin aut Gabriele Ghisleni verfasserin aut In Brazilian Journal of Psychiatry Associação Brasileira de Psiquiatria (ABP), 2004 (DE-627)320632717 (DE-600)2024119-7 1809452X nnns https://doi.org/10.1590/1516-4446-2019-0726 kostenfrei https://doaj.org/article/a1c68762b68a403aaf41dd2282d16d04 kostenfrei http://www.scielo.br/pdf/rbp/v43n1/1516-4446-rbp-1516444620190726.pdf kostenfrei http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462021000100006&tlng=en kostenfrei https://doaj.org/toc/1809-452X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR |
allfieldsGer |
10.1590/1516-4446-2019-0726 doi (DE-627)DOAJ064381137 (DE-599)DOAJa1c68762b68a403aaf41dd2282d16d04 DE-627 ger DE-627 rakwb eng por RC435-571 Renata B. Peters verfasserin aut BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Objective: Clinical and biological correlates of resilience in major depressive disorder are scarce. We aimed to investigate the effect of the Val66Met polymorphism in the BDNF gene on resilience scores in major depressive disorder patients and evaluate the polymorphism’s moderation effect on resilience scores in response to cognitive therapy. Method: A total of 106 major depressive disorder patients were enrolled in this clinical randomized study. The Resilience Scale and the Hamilton Rating Scale for Depression were applied at baseline, post-treatment, and at six months of follow-up. Blood samples were obtained at baseline for molecular analysis. Results: The baseline resilience scores were higher in patients with the Met allele (114.6±17.6) than in those with the Val/Val genotype (104.04±21.05; p = 0.037). Cognitive therapy treatment increased resilience scores (p ≤ 0.001) and decreased depressive symptoms (p ≤ 0.001). In the mixed-effect model, the Val/Val genotype represented a decrease in resilience scores (t218 = -1.98; p = 0.048), and the Val66Met polymorphism interacted with sex to predict an increase in total resilience scores during cognitive treatment (t218 = 2.69; p = 0.008). Conclusion: Our results indicate that cognitive therapy intervention could improve resilience in follow-up, considering that gender and genetic susceptibility are predicted by the Val66Met polymorphism. Resilience Val66Met polymorphism psychotherapy Psychiatry Janaína Xavier verfasserin aut Thaíse C. Mondin verfasserin aut Taiane de A. Cardoso verfasserin aut Fabiana B. Ferreira verfasserin aut Liana Teixeira verfasserin aut Kiane Gräeff verfasserin aut Luciana de A. Quevedo verfasserin aut Karen Jansen verfasserin aut Luciano D. Souza verfasserin aut Jean P. Oses verfasserin aut Ricardo T. Pinheiro verfasserin aut Ricardo A. da Silva verfasserin aut Gabriele Ghisleni verfasserin aut In Brazilian Journal of Psychiatry Associação Brasileira de Psiquiatria (ABP), 2004 (DE-627)320632717 (DE-600)2024119-7 1809452X nnns https://doi.org/10.1590/1516-4446-2019-0726 kostenfrei https://doaj.org/article/a1c68762b68a403aaf41dd2282d16d04 kostenfrei http://www.scielo.br/pdf/rbp/v43n1/1516-4446-rbp-1516444620190726.pdf kostenfrei http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462021000100006&tlng=en kostenfrei https://doaj.org/toc/1809-452X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR |
allfieldsSound |
10.1590/1516-4446-2019-0726 doi (DE-627)DOAJ064381137 (DE-599)DOAJa1c68762b68a403aaf41dd2282d16d04 DE-627 ger DE-627 rakwb eng por RC435-571 Renata B. Peters verfasserin aut BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Objective: Clinical and biological correlates of resilience in major depressive disorder are scarce. We aimed to investigate the effect of the Val66Met polymorphism in the BDNF gene on resilience scores in major depressive disorder patients and evaluate the polymorphism’s moderation effect on resilience scores in response to cognitive therapy. Method: A total of 106 major depressive disorder patients were enrolled in this clinical randomized study. The Resilience Scale and the Hamilton Rating Scale for Depression were applied at baseline, post-treatment, and at six months of follow-up. Blood samples were obtained at baseline for molecular analysis. Results: The baseline resilience scores were higher in patients with the Met allele (114.6±17.6) than in those with the Val/Val genotype (104.04±21.05; p = 0.037). Cognitive therapy treatment increased resilience scores (p ≤ 0.001) and decreased depressive symptoms (p ≤ 0.001). In the mixed-effect model, the Val/Val genotype represented a decrease in resilience scores (t218 = -1.98; p = 0.048), and the Val66Met polymorphism interacted with sex to predict an increase in total resilience scores during cognitive treatment (t218 = 2.69; p = 0.008). Conclusion: Our results indicate that cognitive therapy intervention could improve resilience in follow-up, considering that gender and genetic susceptibility are predicted by the Val66Met polymorphism. Resilience Val66Met polymorphism psychotherapy Psychiatry Janaína Xavier verfasserin aut Thaíse C. Mondin verfasserin aut Taiane de A. Cardoso verfasserin aut Fabiana B. Ferreira verfasserin aut Liana Teixeira verfasserin aut Kiane Gräeff verfasserin aut Luciana de A. Quevedo verfasserin aut Karen Jansen verfasserin aut Luciano D. Souza verfasserin aut Jean P. Oses verfasserin aut Ricardo T. Pinheiro verfasserin aut Ricardo A. da Silva verfasserin aut Gabriele Ghisleni verfasserin aut In Brazilian Journal of Psychiatry Associação Brasileira de Psiquiatria (ABP), 2004 (DE-627)320632717 (DE-600)2024119-7 1809452X nnns https://doi.org/10.1590/1516-4446-2019-0726 kostenfrei https://doaj.org/article/a1c68762b68a403aaf41dd2282d16d04 kostenfrei http://www.scielo.br/pdf/rbp/v43n1/1516-4446-rbp-1516444620190726.pdf kostenfrei http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462021000100006&tlng=en kostenfrei https://doaj.org/toc/1809-452X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR |
language |
English Portuguese |
source |
In Brazilian Journal of Psychiatry |
sourceStr |
In Brazilian Journal of Psychiatry |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Resilience Val66Met polymorphism psychotherapy Psychiatry |
isfreeaccess_bool |
true |
container_title |
Brazilian Journal of Psychiatry |
authorswithroles_txt_mv |
Renata B. Peters @@aut@@ Janaína Xavier @@aut@@ Thaíse C. Mondin @@aut@@ Taiane de A. Cardoso @@aut@@ Fabiana B. Ferreira @@aut@@ Liana Teixeira @@aut@@ Kiane Gräeff @@aut@@ Luciana de A. Quevedo @@aut@@ Karen Jansen @@aut@@ Luciano D. Souza @@aut@@ Jean P. Oses @@aut@@ Ricardo T. Pinheiro @@aut@@ Ricardo A. da Silva @@aut@@ Gabriele Ghisleni @@aut@@ |
publishDateDaySort_date |
2024-01-01T00:00:00Z |
hierarchy_top_id |
320632717 |
id |
DOAJ064381137 |
language_de |
englisch portugiesisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ064381137</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309035625.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228nuuuuuuuuxx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1590/1516-4446-2019-0726</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ064381137</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJa1c68762b68a403aaf41dd2282d16d04</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">por</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC435-571</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Renata B. Peters</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Objective: Clinical and biological correlates of resilience in major depressive disorder are scarce. We aimed to investigate the effect of the Val66Met polymorphism in the BDNF gene on resilience scores in major depressive disorder patients and evaluate the polymorphism’s moderation effect on resilience scores in response to cognitive therapy. Method: A total of 106 major depressive disorder patients were enrolled in this clinical randomized study. The Resilience Scale and the Hamilton Rating Scale for Depression were applied at baseline, post-treatment, and at six months of follow-up. Blood samples were obtained at baseline for molecular analysis. Results: The baseline resilience scores were higher in patients with the Met allele (114.6±17.6) than in those with the Val/Val genotype (104.04±21.05; p = 0.037). Cognitive therapy treatment increased resilience scores (p ≤ 0.001) and decreased depressive symptoms (p ≤ 0.001). In the mixed-effect model, the Val/Val genotype represented a decrease in resilience scores (t218 = -1.98; p = 0.048), and the Val66Met polymorphism interacted with sex to predict an increase in total resilience scores during cognitive treatment (t218 = 2.69; p = 0.008). Conclusion: Our results indicate that cognitive therapy intervention could improve resilience in follow-up, considering that gender and genetic susceptibility are predicted by the Val66Met polymorphism.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Resilience</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Val66Met polymorphism</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">psychotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Psychiatry</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Janaína Xavier</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Thaíse C. Mondin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Taiane de A. Cardoso</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Fabiana B. Ferreira</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Liana Teixeira</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kiane Gräeff</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Luciana de A. Quevedo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Karen Jansen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Luciano D. Souza</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jean P. Oses</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ricardo T. Pinheiro</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ricardo A. da Silva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Gabriele Ghisleni</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Brazilian Journal of Psychiatry</subfield><subfield code="d">Associação Brasileira de Psiquiatria (ABP), 2004</subfield><subfield code="w">(DE-627)320632717</subfield><subfield code="w">(DE-600)2024119-7</subfield><subfield code="x">1809452X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1590/1516-4446-2019-0726</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/a1c68762b68a403aaf41dd2282d16d04</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.scielo.br/pdf/rbp/v43n1/1516-4446-rbp-1516444620190726.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462021000100006&tlng=en</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1809-452X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Renata B. Peters |
spellingShingle |
Renata B. Peters misc RC435-571 misc Resilience misc Val66Met polymorphism misc psychotherapy misc Psychiatry BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy |
authorStr |
Renata B. Peters |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)320632717 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RC435-571 |
illustrated |
Not Illustrated |
issn |
1809452X |
topic_title |
RC435-571 BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy Resilience Val66Met polymorphism psychotherapy |
topic |
misc RC435-571 misc Resilience misc Val66Met polymorphism misc psychotherapy misc Psychiatry |
topic_unstemmed |
misc RC435-571 misc Resilience misc Val66Met polymorphism misc psychotherapy misc Psychiatry |
topic_browse |
misc RC435-571 misc Resilience misc Val66Met polymorphism misc psychotherapy misc Psychiatry |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Brazilian Journal of Psychiatry |
hierarchy_parent_id |
320632717 |
hierarchy_top_title |
Brazilian Journal of Psychiatry |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)320632717 (DE-600)2024119-7 |
title |
BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy |
ctrlnum |
(DE-627)DOAJ064381137 (DE-599)DOAJa1c68762b68a403aaf41dd2282d16d04 |
title_full |
BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy |
author_sort |
Renata B. Peters |
journal |
Brazilian Journal of Psychiatry |
journalStr |
Brazilian Journal of Psychiatry |
callnumber-first-code |
R |
lang_code |
eng por |
isOA_bool |
true |
recordtype |
marc |
contenttype_str_mv |
txt |
author_browse |
Renata B. Peters Janaína Xavier Thaíse C. Mondin Taiane de A. Cardoso Fabiana B. Ferreira Liana Teixeira Kiane Gräeff Luciana de A. Quevedo Karen Jansen Luciano D. Souza Jean P. Oses Ricardo T. Pinheiro Ricardo A. da Silva Gabriele Ghisleni |
class |
RC435-571 |
format_se |
Elektronische Aufsätze |
author-letter |
Renata B. Peters |
doi_str_mv |
10.1590/1516-4446-2019-0726 |
author2-role |
verfasserin |
title_sort |
bdnf val66met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy |
callnumber |
RC435-571 |
title_auth |
BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy |
abstract |
Objective: Clinical and biological correlates of resilience in major depressive disorder are scarce. We aimed to investigate the effect of the Val66Met polymorphism in the BDNF gene on resilience scores in major depressive disorder patients and evaluate the polymorphism’s moderation effect on resilience scores in response to cognitive therapy. Method: A total of 106 major depressive disorder patients were enrolled in this clinical randomized study. The Resilience Scale and the Hamilton Rating Scale for Depression were applied at baseline, post-treatment, and at six months of follow-up. Blood samples were obtained at baseline for molecular analysis. Results: The baseline resilience scores were higher in patients with the Met allele (114.6±17.6) than in those with the Val/Val genotype (104.04±21.05; p = 0.037). Cognitive therapy treatment increased resilience scores (p ≤ 0.001) and decreased depressive symptoms (p ≤ 0.001). In the mixed-effect model, the Val/Val genotype represented a decrease in resilience scores (t218 = -1.98; p = 0.048), and the Val66Met polymorphism interacted with sex to predict an increase in total resilience scores during cognitive treatment (t218 = 2.69; p = 0.008). Conclusion: Our results indicate that cognitive therapy intervention could improve resilience in follow-up, considering that gender and genetic susceptibility are predicted by the Val66Met polymorphism. |
abstractGer |
Objective: Clinical and biological correlates of resilience in major depressive disorder are scarce. We aimed to investigate the effect of the Val66Met polymorphism in the BDNF gene on resilience scores in major depressive disorder patients and evaluate the polymorphism’s moderation effect on resilience scores in response to cognitive therapy. Method: A total of 106 major depressive disorder patients were enrolled in this clinical randomized study. The Resilience Scale and the Hamilton Rating Scale for Depression were applied at baseline, post-treatment, and at six months of follow-up. Blood samples were obtained at baseline for molecular analysis. Results: The baseline resilience scores were higher in patients with the Met allele (114.6±17.6) than in those with the Val/Val genotype (104.04±21.05; p = 0.037). Cognitive therapy treatment increased resilience scores (p ≤ 0.001) and decreased depressive symptoms (p ≤ 0.001). In the mixed-effect model, the Val/Val genotype represented a decrease in resilience scores (t218 = -1.98; p = 0.048), and the Val66Met polymorphism interacted with sex to predict an increase in total resilience scores during cognitive treatment (t218 = 2.69; p = 0.008). Conclusion: Our results indicate that cognitive therapy intervention could improve resilience in follow-up, considering that gender and genetic susceptibility are predicted by the Val66Met polymorphism. |
abstract_unstemmed |
Objective: Clinical and biological correlates of resilience in major depressive disorder are scarce. We aimed to investigate the effect of the Val66Met polymorphism in the BDNF gene on resilience scores in major depressive disorder patients and evaluate the polymorphism’s moderation effect on resilience scores in response to cognitive therapy. Method: A total of 106 major depressive disorder patients were enrolled in this clinical randomized study. The Resilience Scale and the Hamilton Rating Scale for Depression were applied at baseline, post-treatment, and at six months of follow-up. Blood samples were obtained at baseline for molecular analysis. Results: The baseline resilience scores were higher in patients with the Met allele (114.6±17.6) than in those with the Val/Val genotype (104.04±21.05; p = 0.037). Cognitive therapy treatment increased resilience scores (p ≤ 0.001) and decreased depressive symptoms (p ≤ 0.001). In the mixed-effect model, the Val/Val genotype represented a decrease in resilience scores (t218 = -1.98; p = 0.048), and the Val66Met polymorphism interacted with sex to predict an increase in total resilience scores during cognitive treatment (t218 = 2.69; p = 0.008). Conclusion: Our results indicate that cognitive therapy intervention could improve resilience in follow-up, considering that gender and genetic susceptibility are predicted by the Val66Met polymorphism. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
title_short |
BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy |
url |
https://doi.org/10.1590/1516-4446-2019-0726 https://doaj.org/article/a1c68762b68a403aaf41dd2282d16d04 http://www.scielo.br/pdf/rbp/v43n1/1516-4446-rbp-1516444620190726.pdf http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462021000100006&tlng=en https://doaj.org/toc/1809-452X |
remote_bool |
true |
author2 |
Janaína Xavier Thaíse C. Mondin Taiane de A. Cardoso Fabiana B. Ferreira Liana Teixeira Kiane Gräeff Luciana de A. Quevedo Karen Jansen Luciano D. Souza Jean P. Oses Ricardo T. Pinheiro Ricardo A. da Silva Gabriele Ghisleni |
author2Str |
Janaína Xavier Thaíse C. Mondin Taiane de A. Cardoso Fabiana B. Ferreira Liana Teixeira Kiane Gräeff Luciana de A. Quevedo Karen Jansen Luciano D. Souza Jean P. Oses Ricardo T. Pinheiro Ricardo A. da Silva Gabriele Ghisleni |
ppnlink |
320632717 |
callnumber-subject |
RC - Internal Medicine |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.1590/1516-4446-2019-0726 |
callnumber-a |
RC435-571 |
up_date |
2024-07-03T22:36:45.177Z |
_version_ |
1803599169644920832 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ064381137</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309035625.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228nuuuuuuuuxx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1590/1516-4446-2019-0726</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ064381137</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJa1c68762b68a403aaf41dd2282d16d04</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">por</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC435-571</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Renata B. Peters</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">BDNF Val66Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Objective: Clinical and biological correlates of resilience in major depressive disorder are scarce. We aimed to investigate the effect of the Val66Met polymorphism in the BDNF gene on resilience scores in major depressive disorder patients and evaluate the polymorphism’s moderation effect on resilience scores in response to cognitive therapy. Method: A total of 106 major depressive disorder patients were enrolled in this clinical randomized study. The Resilience Scale and the Hamilton Rating Scale for Depression were applied at baseline, post-treatment, and at six months of follow-up. Blood samples were obtained at baseline for molecular analysis. Results: The baseline resilience scores were higher in patients with the Met allele (114.6±17.6) than in those with the Val/Val genotype (104.04±21.05; p = 0.037). Cognitive therapy treatment increased resilience scores (p ≤ 0.001) and decreased depressive symptoms (p ≤ 0.001). In the mixed-effect model, the Val/Val genotype represented a decrease in resilience scores (t218 = -1.98; p = 0.048), and the Val66Met polymorphism interacted with sex to predict an increase in total resilience scores during cognitive treatment (t218 = 2.69; p = 0.008). Conclusion: Our results indicate that cognitive therapy intervention could improve resilience in follow-up, considering that gender and genetic susceptibility are predicted by the Val66Met polymorphism.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Resilience</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Val66Met polymorphism</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">psychotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Psychiatry</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Janaína Xavier</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Thaíse C. Mondin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Taiane de A. Cardoso</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Fabiana B. Ferreira</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Liana Teixeira</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Kiane Gräeff</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Luciana de A. Quevedo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Karen Jansen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Luciano D. Souza</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jean P. Oses</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ricardo T. Pinheiro</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ricardo A. da Silva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Gabriele Ghisleni</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Brazilian Journal of Psychiatry</subfield><subfield code="d">Associação Brasileira de Psiquiatria (ABP), 2004</subfield><subfield code="w">(DE-627)320632717</subfield><subfield code="w">(DE-600)2024119-7</subfield><subfield code="x">1809452X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1590/1516-4446-2019-0726</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/a1c68762b68a403aaf41dd2282d16d04</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.scielo.br/pdf/rbp/v43n1/1516-4446-rbp-1516444620190726.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462021000100006&tlng=en</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1809-452X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield></record></collection>
|
score |
7.401636 |